Sanofi Taps Millions Into AI Platform for Cancer Drug Discovery

Sanofi is investing in French American startup Owkin to support drug discovery and development initiatives in four types of cancer.

The strategic collaboration entails a $180 million equity investment into Owkin and a total payment of $90 million over the next three years, in addition to milestone-based fees to be determined later.